JPRN-UMIN000000950已完成未知
A randomized phase II trial of postoperative adjuvant therapy with imanitib for 1 Year versus 6 months in patients with gastrointestinal stromal tumors - Randomized trial of adjuvant therapy with imanitib for 1 year versus 6 months in GIST patients
Kinki GIST Study Group0 个研究点目标入组 80 人开始时间: 2007年12月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Familial GIST or GIST complicated with von Recklinghausen disease (NF type 1) 2) Active double cancer (synchronous double cancer and metachronous double cancer within 5 disease-free years). Carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer) that are judged as having been cured by local treatment is not included in active double cancer. 3) Prior chemotherapy, radiotherapy, or immunotherapy after resection of lesions 4) Prior treatment with imanitib 5) Cardiac disease assigned to NYHA class III or IV 6) Women who are pregnant, breast-feeding, or planning to become pregnant 7) Active mycosis and other infections 8) Other conditions judged as inappropriate for the study by the investigator
研究者
相似试验
已完成
2 期
A phase II trial of postoperative adjuvant chemotherapy with carboplatin/ docetaxel for the patients completely resected Non Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000002425niversity of Occupational and Environmental Health65
已完成
1 期
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckCTIS2024-513206-65-00Groupe Oncologie Radiotherapie Tete Cou674
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckSquamous cell carcinoma treated by primary surgeryStage III, stage IV (American Joint Committee on Cancer 7th edition)Oral cavity, oropharynx, hypopharynx or larynxMedDRA version: 21.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004936-13-PLGORTEC680
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckEUCTR2017-004936-13-GRGORTEC680